Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-022682

Chief Executive Officer sold 30,000 shares at an average $35.59 ($1,067,611)

From the SEC's structured data for this filing

Trades in this filing

Lynch Casey · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-22 Sale : show line 1 in the form −11,211 $35.10 $393,506 1,027,563 I
2021-03-22 Sale : show line 2 in the form −18,089 $35.85 $648,491 1,009,474 I
2021-03-22 Sale : show line 3 in the form −300 $36.58 $10,974 1,009,174 I
2021-03-22 Sale : show line 4 in the form −400 $36.60 $14,640 1,008,774 I
Open-market sales · 30,000 sh · avg $35.59 · $1,067,611
Loading xslF345X03/doc4.xml…